Sevda Demir is an expert in Infectiology at Yeditepe University (Turkey). Sevda Demir has authored 16 publications, the most recent in 2026. SLR score: 36 (community average: 125). How the SLR is computed.

LeadR Profile

Sevda Demir, PhD Yeditepe University Turkey
36 ScienceLeadR Reputation 36
Network Map

Infectiology

Subspecialties:

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2020 - 2026

Source: PubMed

Yeditepe University

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 16

Citations

Citations: 210 1st author: 4 Last author: 0 Unique author: 0


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Effects of extremely low-frequency sinusoidal electromagnetic field therapy on survival and vascularization in a rat random-pattern skin flap model.
PMID 42326047 — skin, genes, therapeutics
JPRAS Open20260
Comparison of strain specific pathogenicity of Herpes Simplex Virus Type 1 by high-throughput sequencing.
PMID 38971379 — genes, herpes simplex, spinal cord, cold temperature, virology, brain, simplexvirus, herpesvirus 1, human, viruses, therapeutics, herpes labialis, mutation, lip, spine
J Virol Methods20242
A comparative study of glutathione-coated iron oxide and glutathione-coated core-shell magnetic nanoparticles for their antiviral activities
OpenAlex W4400972961 — nanoparticles, herpesvirus 1, human, viruses, antiviral agents, glutathione
The European Chemistry and Biotechnology Journal20240
Botulism after intragastric botulinum toxin injections for weight reduction.
PMID 37584071 — evidence-based medicine, botulinum toxins, injections, risk, botulism, nervous system diseases, weight loss, off-label use, obesity
Eur J Neurol20233
Preclinical Studies on Convalescent Human Immune Plasma-Derived Exosome: Omics and Antiviral Properties to SARS-CoV-2.
PMID 35401544 — immune system diseases, plasma, antiviral agents, exosomes, sars virus, covid-19, sars-cov-2
Front Immunol202210

LeadR Networks

Main global connection map